Which of the following best describes the concept of 'original antigenic sin' in the context of vaccinology, and what are its implications for sequential vaccination strategies?
Question 2
A novel vaccine platform aims to induce mucosal immunity to prevent respiratory viral infections. Which of the following immune mechanisms is most critical for achieving this goal, and why is it often challenging to elicit effectively through systemic vaccination?
Question 3
In the context of vaccine development for a highly variable pathogen, what is the primary advantage of a 'universal vaccine' approach over traditional strain-specific vaccines, and what is the major hurdle in its realization?
Question 4
Consider a vaccine development program for a pathogen that primarily causes disease through the production of a potent exotoxin. Which vaccine strategy would be most effective in preventing the disease symptoms, and why?
Question 5
A vaccine is being developed for a pathogen that exhibits significant antigenic variation, making it difficult to achieve long-term protection with traditional vaccines. Which of the following strategies represents the most promising approach to overcome this challenge?
